A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the efficacy and safety of fluticasone
furoate/vilanterol Inhalation Powder compared with placebo over a 24 weeks treatment period
in subjects of Asian ancestry with Chronic Obstructive Pulmonary Disease (COPD).